Gao Y, Lü R, Wang X, Geng J, Ren K, Wang Y, Zhao J, Yu X, Chen D
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine and Pharmacy.
J Tradit Chin Med. 1998 Dec;18(4):247-52.
This paper reports the clinical trial of Tang Shen Ning ([symbol: see text], TSN) for treating diabetic nephropathy (incipient and clinical, as divided by Mogensen). The results showed that the total effective rate in treatment group (TSN + western medicine) was 90.0%, and that in the control group (simply with western medicine), 56.7%. TSN plays important roles in decreasing proteinuria and improving renal functions.
